Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1308 studies found for:    LEUKEMIA, CHRONIC MYELOID
Show Display Options
Rank Status Study
1 Recruiting Study of Imatinib Discontinuation in Chronic Myeloid Leukemia With Deep Molecular Response
Condition: Leukemia, Chronic Myeloid
Interventions: Drug: Pioglitazone;   Other: imatinib discontinuation
2 Withdrawn RAD001 in Patients With Chronic Phase Chronic Myeloid Leukemia w/ Molecular Disease.
Condition: Chronic Myeloid Leukemia
Interventions: Drug: RAD001;   Drug: Imatinib
3 Recruiting Regional Central Database Recording of Chronic Myeloid Leukemia
Condition: Chronic Myeloid Leukemia
Intervention: Other: Practices evaluation
4 Recruiting Bosutinib in Elderly Chronic Myeloid Leukemia
Condition: Chronic Myeloid Leukemia
Intervention: Drug: Bosutinib
5 Recruiting Phase IV EORTC Quality of Life Module for Patients With Chronic Myeloid Leukemia
Condition: Chronic Myeloid Leukemia
Intervention:
6 Active, not recruiting Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Condition: Chronic Myeloid Leukemia
Intervention: Other: Non-Interventional
7 Completed
Has Results
Dasatinib (BMS-354835) Versus Imatinib Mesylate in Subjects With Chronic Myeloid Leukemia
Conditions: Chronic Myeloid Leukemia;   Philadelphia-Positive Myeloid Leukemia
Interventions: Drug: Dasatinib;   Drug: Imatinib
8 Completed
Has Results
Study of BMS-354825 (Dasatinib) in Patients With Chronic Myeloid Leukemia Who Are Either Resistant or Intolerant to Imatinib
Conditions: Chronic Myeloid Leukemia;   Philadelphia-Positive Myeloid Leukemia
Intervention: Drug: Dasatinib
9 Completed A Study of Dasatinib in Patients With Imatinib Resistant or Intolerant Chronic Myeloid Leukemia
Condition: Chronic Myeloid Leukemia
Intervention: Drug: dasatinib
10 Completed A Study of Complete Molecular Response for Chronic Myeloid Leukemia in Chronic Phase Patients, Treated With Dasatinib
Condition: Chronic Myeloid Leukemia
Intervention: Drug: dasatinib
11 Completed
Has Results
Study of Dasatinib (BMS-354825) in Patients With Accelerated Phase Chronic Myeloid Leukemia
Condition: Chronic Myelogenous Leukemia
Intervention: Drug: Dasatinib
12 Completed Glivec® (Imatinib Mesylate, STI571) in Monotherapy Versus Glivec®-Interferon Alpha in the Treatment of Chronic-Phase Chronic Myeloid Leukaemia
Condition: Chronic Myeloid Leukaemia
Interventions: Drug: Glivec;   Drug: Interferon
13 Completed Pulmonary Vasculopathy Under Second-line Therapy of Chronic Myeloid Leukemia
Condition: Chronic Myeloid Leukemia
Intervention: Other: Echo, exercise echo, and if indicated, right heart catheter
14 Not yet recruiting Multicenter, PhaseⅣ, Open Label Trial of Nilotinib in Adult Patients Diagnosed Philadelphia Chromosome Positive(Ph+) Chronic Myeloid Leukemia in CP/AP Intolerant to Dasatinib
Condition: Leukemia, Chronic Myeloid
Intervention: Drug: Nilotinib
15 Completed Autologous Cytokine Induced Killer Cells (CIK) for Chronic Myeloid Leukemia (CML) Patients on Standard Drug Therapy
Condition: Chronic Myeloid Leukemia
Intervention: Biological: Autologous CIK cell infusion
16 Completed Patient Reported Outcomes in Chronic Myeloid Leukemia
Condition: Chronic Myeloid Leukemia
Intervention: Other: HRQOL questionnaire
17 Recruiting Front-line Treatment of BCR-ABL+ Chronic Myeloid Leukemia (CML) With Dasatinib
Condition: Chronic Myeloid Leukemia
Intervention: Behavioral: Dasatinib discontinuation
18 Recruiting LEONIDAS: Quality of Life Study in Chronic Myeloid Leukemia Patients
Condition: Chronic Myeloid Leukemia
Intervention: Other: QoL Survey Booklet
19 Completed
Has Results
Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients
Condition: Chronic Myeloid Leukemia
Intervention: Drug: Nilotinib
20 Completed Study of Treatment With Nilotinib in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase
Condition: Chronic Myeloid Leukemia
Intervention: Drug: Nilotinib

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.